First demonstrated by Shinya Yamanaka's lab in 2006, the induced pluripotent stem cells (iPSCs) can be generated from different adult somatic cell types by the introduction of four transcription factors (OCT4, SOX2, KLF4, and MYC). With the pluripotency similar to embryonic stem cells (ESCs), iPSCs have shown great potential in drug discovery, disease modeling, and regenerative medicine research. Read Full Article: qPCR Analysis for Pluripotency Markers for iPSC
1 Vote
Created
alex jamess 5 months ago
A contemporary design brand blending traditional craftsmanship with modern aesthetics, focused on creating sustainable, minimalist furniture. La Fuori
mr jhon 18 days ago
Induced pluripotent stem cells (iPSCs) are indeed a breakthrough in regenerative medicine and disease modeling, with immense potential. Just as iPSCs represent a new frontier in research, tools like HappyLoop offer examples of data analytics that drive innovation in business. By automating complex data processes, HappyLoop helps companies turn raw data into actionable insights, similar to how iPSCs offer new possibilities for medical science. Both illustrate how powerful data-driven advancements can open up new possibilities in their respective fields.